Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Gs Caltex Corporation has 4 pending office actions in Biotechnology & Pharmaceuticals. Those matters involve 4 distinct examiners and 4 distinct art units, indicating that the pending work is distributed across separate examination assignments rather than concentrated in one unit.
MISHRA, DEEPA is the busiest examiner, with 1 pending action. Prosecution planning should account for examiner-specific issues across the portfolio, because the recorded assignments do not identify one examiner or art unit as the principal source of activity.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| Double-patenting + other | 1 (25%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MISHRA, DEEPA | 1 | 28.9% | +35.5% |
| MOEHLMAN, ANDREW TERRY | 1 | 67.0% | +59.7% |
| RAMIREZ, DELIA M | 1 | 65.1% | +56.3% |
| SINGH, PREM C | 1 | 58.9% | +33.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18691728 | RECOMBINANT MICROORGANISM WITH CONTROLLED ABILITY TO PRODUCE POLYOLS OR EXOPOLYMERS | MISHRA, DEEPA | 22d |
| 18569887 | METHOD FOR OBTAINING DESIRED COMPOUND FROM FERMENTATION BROTH | MOEHLMAN, ANDREW TERRY | — |
| 18285340 | RECOMBINANT MICROORGANISM FOR PRODUCING 2,3-BUTANEDIOL WITH REDUCED BY-PRODUCT PRODUCTION AND METHOD FOR PRODUCING 2,3-BUTANEDIOL BY USING SAME | RAMIREZ, DELIA M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18691728 | RECOMBINANT MICROORGANISM WITH CONTROLLED ABILITY TO PRODUCE POLYOLS OR EXOPOLYMERS | MISHRA, DEEPA | 22d |
| 18109444 | METHOD FOR PREPARING ALKYL CARBOXYLIC ACID ESTER AND APPARATUS FOR PREPARING ALKYL CARBOXYLIC ACID ESTER | SINGH, PREM C | 75d |
| 18569887 | METHOD FOR OBTAINING DESIRED COMPOUND FROM FERMENTATION BROTH | MOEHLMAN, ANDREW TERRY | — |
| 18285340 | RECOMBINANT MICROORGANISM FOR PRODUCING 2,3-BUTANEDIOL WITH REDUCED BY-PRODUCT PRODUCTION AND METHOD FOR PRODUCING 2,3-BUTANEDIOL BY USING SAME | RAMIREZ, DELIA M | — |
| Art Unit | Apps |
|---|---|
| 1657 | 1 |
| 1655 | 1 |
| 1652 | 1 |
| 1771 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18691728 | RECOMBINANT MICROORGANISM WITH CONTROLLED ABILITY TO PRODUCE POLYOLS OR EXOPOLYMERS | MISHRA, DEEPA | 1657 | §102§103DP | Final Rejection | 22d | Pending | Apr 11, 2024 |
| 18569887 | METHOD FOR OBTAINING DESIRED COMPOUND FROM FERMENTATION BROTH | MOEHLMAN, ANDREW TERRY | 1655 | §102§103§112 | Final Rejection | — | Pending | Dec 13, 2023 |
| 18285340 | RECOMBINANT MICROORGANISM FOR PRODUCING 2,3-BUTANEDIOL WITH REDUCED BY-PRODUCT PRODUCTION AND METHOD FOR PRODUCING 2,3-BUTANEDIOL BY USING SAME | RAMIREZ, DELIA M | 1652 | §102§103§112 | Final Rejection | — | Pending | Oct 02, 2023 |
| 18109444 | METHOD FOR PREPARING ALKYL CARBOXYLIC ACID ESTER AND APPARATUS FOR PREPARING ALKYL CARBOXYLIC ACID ESTER | SINGH, PREM C | 1771 | §103 | Non-Final OA | 75d | Pending | Feb 14, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGs Caltex Corporation has 4 pending office actions as of October 2026, spread across 4 art units and 4 examiners.
Deepa Mishra has the most, with 1 of Gs Caltex Corporation's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
